Danaher Reports First Quarter 2024 Results

Go back to Danaher Reports First Quarter 2024 Results

Danaher (DHR) PT Raised to $270 at BofA Securities

April 24, 2024 5:35 AM EDT

BofA Securities analyst Michael Ryskin raised the price target on Danaher (NYSE: DHR) to $270.00 (from $258.00) while maintaining a Neutral rating.

The analyst comments "While DHR did not change any of its underlying assumptions for Bioprocessing in FY24, we do see continued signs... More

Deutsche Bank on Danaher (DHR): 'We expect strength in DHR stock'

April 23, 2024 8:26 AM EDT

Deutsche Bank analyst Justin Bowers reiterated a Buy rating and $270.00 price target on Danaher (NYSE: DHR).

The analyst comments "We expect strength in DHR stock after a solid 1Q beat and waning sentiment into first quarter results. Danaher topped the Street and our 1Q24... More